TMCnet News
Proteus Digital Health® Founder to Present at World Economic Forum in DavosProteus (News - Alert) Digital Health® announced today that Andrew Thompson, its President, Chief Executive Officer and Co-Founder, will present on the progress of Proteus' digital medicines to improve patient treatment and outcomes at the 2019 World Economic Forum Annual Meeting in Davos-Klosters, Switzerland. Mr. Thompson will present on the official programme:
Mr. Thompson will also present at two other events during the World Economic Forum Meeting:
January 22 at 8:05 p.m., Polish House:
January 23 at 7:00 a.m., A.T. Kearney Glass House: About Proteus Digital Health Proteus Digital Health is enabling a new category of pharmaceuticals: Digital Medicines. These include widely used drugs, formulated so they communicate when they have been ingested; a wearable patch that detects medicines and captures physiologic response; mobile applications to support patient self-care and physician decision-making; and data analytics to serve the needs of health system managers. The company has more than 540 issued patents that protect this enabling technology, and regulatory clearances in the U.S., European Union and China. Proteus Digital Health is privately held by investors that include Carlyle, Essex Woodlands, Kaiser Permanente®, Medtronic®, Novartis®, Otsuka, and ON (News - Alert) Semiconductor®. Further information is available at: www.proteus.com. Connect with us on Twitter (News - Alert) @ProteusDH. For more information, please visit www.proteus.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190121005423/en/ |